Related references
Note: Only part of the references are listed.Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
Rashmi Kanagal-Shamanna et al.
MODERN PATHOLOGY (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - 2021 update on diagnosis, risk-stratification, and management
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)
Guillermo Montalban-Bravo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias
Samuel G. Katz et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Relationship between clone metrics and clinical outcome in clonal cytopenia
Anna Galli et al.
BLOOD (2021)
Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime?
Eric Solary et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
How I investigate chronic myelomonocytic leukemia
Valentina Fabiola Ilenia Sangiorgio et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients
Giacomo Coltro et al.
LEUKEMIA (2020)
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati et al.
BLOOD (2020)
Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study
Kathryn Foucar et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo et al.
BLOOD (2020)
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
Xavier Calvo et al.
BLOOD ADVANCES (2020)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent et al.
HAEMATOLOGICA (2019)
The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis
Catherine Cargo et al.
BLOOD (2019)
Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis
Zhihong Hu et al.
HUMAN PATHOLOGY (2019)
Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia
Jennifer Chapman et al.
MODERN PATHOLOGY (2018)
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations
Hatice D. Gur et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Atypical chronic myeloid leukemia: a rare entity with management challenges
Prajwal Dhakal et al.
FUTURE ONCOLOGY (2018)
The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS
Blanca Xicoy et al.
LEUKEMIA RESEARCH (2018)
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories
Sanam Loghavi et al.
BLOOD ADVANCES (2018)
Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia
Mohammad Faizan Zahid et al.
LEUKEMIA & LYMPHOMA (2017)
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
Sa A. Wang et al.
HAEMATOLOGICA (2017)
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
Julia T. Geyer et al.
MODERN PATHOLOGY (2017)
Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis
M. M. Patnaik et al.
BLOOD CANCER JOURNAL (2017)
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
Sa A. Wang et al.
HAEMATOLOGICA (2017)
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance
Rangit Vallapureddy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Michael W. N. Deininger et al.
NATURE REVIEWS CANCER (2017)
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
Peter L. Greenberg et al.
BLOOD (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
Rashmi Kanagal-Shamanna et al.
ONCOTARGET (2016)
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
Dorothee Selimoglu-Buet et al.
BLOOD (2015)
A Close Association of Autoimmune-Mediated Processes and Autoimmune Disorders with Chronic Myelomonocytic Leukemia: Observation from a Single Institution
Deniz Peker et al.
ACTA HAEMATOLOGICA (2015)
Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
Sabine Jeromin et al.
HAEMATOLOGICA (2015)
Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database
Smith Giri et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
Clinicopathologic and Molecular Characterization of Myeloid Neoplasms Harboring Isochromosome 17(q10)
Valeria Visconte et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution
Guilin Tang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang et al.
BLOOD (2014)
Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review
Mrinal M. Patnaik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
M. M. Patnaik et al.
LEUKEMIA (2014)
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such et al.
BLOOD (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
Leonardo Boiocchi et al.
MODERN PATHOLOGY (2013)
Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia
Elizabeth L. Courville et al.
MODERN PATHOLOGY (2013)
Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
J. Broseus et al.
LEUKEMIA (2013)
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
M. Meggendorfer et al.
LEUKEMIA (2013)
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Rocco Piazza et al.
NATURE GENETICS (2013)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53
Rashmi Kanagal-Shamanna et al.
CANCER (2012)
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
Luca Malcovati et al.
BLOOD (2009)
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
A. Orazi et al.
LEUKEMIA (2008)
Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm
Falko Fend et al.
LEUKEMIA RESEARCH (2008)
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis
M. A. Elliott et al.
LEUKEMIA RESEARCH (2007)
Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology
Attilio Orazi et al.
MODERN PATHOLOGY (2006)
Share Paper
